Frequently Asked Questions
The market is segmented based on U.S. Tuberous Sclerosis Drugs Market, By Gene (TSC2, TSC1), Site (Brain, Kidney, Skin, Heart, Lungs, Others), Drug Class (mTOR inhibitors, Anti-Convulsants, Cannabidiol or Epidiolex, Others), Drug Type (Branded, Generics), Population Type (Children, Adults), Route of Administration (Oral, Parenteral, Others), End User (Hospitals, Specialty Clinics, Academic & Research Institutes and Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
.
The Us Tuberous Sclerosis Drug Market size was valued at USD 237.20 USD Million in 2022.
The Us Tuberous Sclerosis Drug Market is projected to grow at a CAGR of 23.1% during the forecast period of 2023 to 2030.
